Hepatitis: all 3,372 studies
Page 21 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to SteroidTerminatedNCT02442180Phase 3
- Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)CompletedNCT02439567Not applicable
- Biomarkers of Liver FibrosisTerminatedNCT02438917
- A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesCompletedNCT02434848Phase 2/3
- Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B SubjectsCompletedNCT02431312Phase 1
- Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthCompletedNCT02428491Phase 3
- Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related QualityCompletedNCT02427204
- The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk FactorsStatus unknownNCT02419625Not applicable
- A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)CompletedNCT02417597Phase 4
- Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver TransplantationStatus unknownNCT02417207Phase 4
- Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon TherapyStatus unknownNCT02412592
- The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor InjectionStatus unknownNCT02412319Phase 4
- Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central AfricaCompletedNCT02405013Phase 2
- Alcohol Diet and Drug Use Preceding Alcoholic HepatitisStatus unknownNCT02404636
- Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in TaiwanCompletedNCT02402699
- Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV PatientsCompletedNCT02401737Phase 1
- Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted PatientsStatus unknownNCT02395198
- Prevalence and Screening of Hepatitis C in Belgium in 2015CompletedNCT02393365Not applicable
- A Hepatitis B With Hepatic Steatosis StudyStatus unknownNCT02392598
- A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT02391805Phase 2
- Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B PatientsStatus unknownNCT02387684
- Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT02387463
- The Hepatitis Delta International NetworkCompletedNCT02375906
- A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4Status unknownNCT02371408Phase 2/3
- Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)CompletedNCT02368522
- Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02368288Phase 4
- Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis BStatus unknownNCT02366247Phase 3
- Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis BCompletedNCT02366208Phase 2
- Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02365402Phase 4
- The Influence of Short-term Starvation on Hepatitis B Virus LoadStatus unknownNCT02364661Not applicable
- The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network ApproachStatus unknownNCT02363517Phase 3
- Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) AnaloguesStatus unknownNCT02362490Phase 4
- Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, CambodiaCompletedNCT02361541
- Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B PatientsCompletedNCT02360592Phase 4
- Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infectionCompletedNCT02355951Not applicable
- Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon TreatmentStatus unknownNCT02348502
- Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East AfricaActive, not recruitingNCT02344498
- Empowering Immigrants in the Greater Boston Area to Connect to HBV CareStatus unknownNCT02342821
- First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1CompletedNCT02339207Phase 1
- TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedNCT02338674Phase 1/2
- Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsStatus unknownNCT02337127Phase 4
- A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug UseCompletedNCT02336139Phase 2
- Effect of Probiotics on Gut-Liver Axis of Alcoholic HepatitisStatus unknownNCT02335632Phase 4
- Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life ConditionsCompletedNCT02333292
- A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis BCompletedNCT02332473Phase 2
- Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive PatientsStatus unknownNCT02327715Phase 4
- Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B PatientsStatus unknownNCT02327702Phase 4
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownNCT02327689Phase 4
- Emtricitabine for Naive Child Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327676Phase 4
- Emtricitabine for Naive Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327663Phase 4
- A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)Status unknownNCT02327416Phase 3
- Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic HepatitisCompletedNCT02326103Early Phase 1
- This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of AgeCompletedNCT02324218
- Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B VaccinationCompletedNCT02323308
- Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in UgandaCompletedNCT02316444Phase 4
- Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.TerminatedNCT02315638
- HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus InfectionCompletedNCT02309918Phase 2
- Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis CTerminatedNCT02309086Phase 1/2
- The Effects of Honey, as a Dietary Supplement in Children With Hepatitis ACompletedNCT02300792Phase 2
- Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based TherapiesTerminatedNCT02293941Phase 2
- Impact of HCV Treatment on Neurocognitive Functions and Brain MetabolismWithdrawnNCT02292966Phase 4
- Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis BTerminatedNCT02288208Phase 1
- Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis BStatus unknownNCT02287857Not applicable
- Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative ResectionStatus unknownNCT02281266Phase 4
- An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus InfectionCompletedNCT02278419Phase 2
- Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)CompletedNCT02269059Phase 1
- Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney FunctionStatus unknownNCT02267473
- Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis BCompletedNCT02263755
- Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic ImpairmentCompletedNCT02259855Phase 1
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B InfectionTerminatedNCT02258581
- Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus InfectionCompletedNCT02254707Phase 1/2
- Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus InfectionCompletedNCT02253550Phase 2
- Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis CCompletedNCT02250001
- Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis BCompletedNCT02249988Phase 2/3
- Follow-up of HBsAg Inactive Carriers StudyCompletedNCT02247752Not applicable
- Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02241590Phase 4
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infectionCompletedNCT02233075Phase 2
- Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT02226952Phase 1/2
- Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis CCompletedNCT02226939Phase 2
- Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot StudyCompletedNCT02220868Phase 4
- Effect of Camel Milk on Chronic Hepatitis CCompletedNCT02216045Phase 2
- Safety Study of the Aethlon HemopurifierTerminatedNCT02215902Not applicable
- A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis CWithdrawnNCT02206932Phase 4
- Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066)WithdrawnNCT02204475Phase 3
- Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected SubjectsCompletedNCT02202473Phase 4
- An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B StudyCompletedNCT02201407
- Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."CompletedNCT02196064
- An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced CirrhosisCompletedNCT02195440Phase 1
- Rapid Diagnostics for HIV and HepatitisWithdrawnNCT02190305Not applicable
- Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）CompletedNCT02189603Phase 4
- Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-IDCompletedNCT02186977Phase 1
- Tenofovir to Prevent HBV ReactivationStatus unknownNCT02186574Phase 3
- A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced HepatitisCompletedNCT02182167Phase 2/3
- Hepatitis C Alcohol Reduction TreatmentCompletedNCT02176980Not applicable
- Two-way Interaction Between Alisporivir and EDP239CompletedNCT02173574Phase 1
- Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT ConsortiumCompletedNCT02172898
- Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver DiseasesStatus unknownNCT02171949Phase 2
- Observational Study on Patients With Chronic Hepatitis BStatus unknownNCT02167503
- Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) AssayCompletedNCT02167113